• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

记忆缺陷与 P301S MAPT 转基因小鼠中的 tau 和脊柱病理学相关。

Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.

机构信息

Department of Neurology, Technical University Munich, Munich, Germany; Department of Translational Neurodegeneration, German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.

出版信息

Neuropathol Appl Neurobiol. 2014 Dec;40(7):833-43. doi: 10.1111/nan.12160.

DOI:10.1111/nan.12160
PMID:24865638
Abstract

AIM

P301S MAPT transgenic mice (P301S mice) are a widely used model of frontotemporal dementia and parkinsonism linked to chromosome 17 with tau pathology (FTDP-17-tau). However, a systematic correlation between cognitive deficits and cellular tau pathology at different ages is still missing. Therefore, our study investigated memory deficits of P301S mice in relation to pathological tau species and dendritic spine pathology throughout adulthood.

METHODS

We analysed P301S mice behaviourally with the novel open field, rotarod, and Morris water maze tests to measure deficits in locomotion, balance and cognition, respectively; immunohistochemically with different tau antibodies for specific tau species; and with Golgi staining for dendritic spine pathology.

RESULTS

We confirmed the occurrence of locomotor deficits at an age of 5 months and newly report memory deficits from 2.5 months of age onwards. At this early age, MC1 and CP13, but not AT180 immunoreactivity, was prominent in the hippocampus of P301S mice. Neuronal cell loss in the hippocampus of P301S mice was not observed to occur till 6 months of age. However, there was a significant reduction in the density of dendritic spines from young adulthood onwards in hippocampal pyramidal neurones.

CONCLUSION

In P301S mice, memory deficits precede the onset of locomotor dysfunction and coincide with the appearance of conformationally changed, S202-phosphorylated tau and reduced spine density in the absence of neuronal cell loss in the hippocampus. Our finding provides insights into the toxic effects of different tau species in vivo and may facilitate the development of new therapies against neurodegenerative tauopathies.

摘要

目的

P301S MAPT 转基因小鼠(P301S 小鼠)是一种广泛用于研究与 17 号染色体相关的额颞叶痴呆和帕金森病伴 tau 病理学(FTDP-17-tau)的模型。然而,不同年龄认知缺陷与细胞 tau 病理学之间的系统相关性仍然缺失。因此,我们的研究调查了 P301S 小鼠在整个成年期与病理 tau 物种和树突棘病理相关的记忆缺陷。

方法

我们使用新的旷场、转棒和 Morris 水迷宫测试对 P301S 小鼠进行行为分析,以分别测量运动、平衡和认知缺陷;使用不同的 tau 抗体进行免疫组织化学分析,以检测特定的 tau 物种;并用 Golgi 染色检测树突棘病理。

结果

我们证实了 P301S 小鼠在 5 月龄时出现运动缺陷,并新报告了从 2.5 月龄开始的记忆缺陷。在这个早期年龄,MC1 和 CP13,但不是 AT180 免疫反应性,在 P301S 小鼠的海马体中明显存在。直到 6 月龄,P301S 小鼠的海马体神经元丢失才被观察到。然而,从年轻成年开始,海马体锥体神经元的树突棘密度显著降低。

结论

在 P301S 小鼠中,记忆缺陷先于运动功能障碍的发生,并与构象改变的 tau 以及 S202 磷酸化 tau 的出现以及海马体神经元丢失同时发生。我们的发现提供了关于体内不同 tau 物种的毒性作用的见解,并可能有助于开发针对神经退行性 tau 病的新疗法。

相似文献

1
Memory deficits correlate with tau and spine pathology in P301S MAPT transgenic mice.记忆缺陷与 P301S MAPT 转基因小鼠中的 tau 和脊柱病理学相关。
Neuropathol Appl Neurobiol. 2014 Dec;40(7):833-43. doi: 10.1111/nan.12160.
2
Early-onset cognitive deficits and axonal transport dysfunction in P301S mutant tau transgenic mice.P301S突变型tau转基因小鼠的早发性认知缺陷和轴突运输功能障碍
Neurosci Res. 2014 Mar;80:76-85. doi: 10.1016/j.neures.2013.12.006. Epub 2014 Jan 6.
3
A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.一种由天然启动子驱动表达双突变tau的新型转基因小鼠表现出tau蛋白病特征。
Exp Neurol. 2008 Jul;212(1):71-84. doi: 10.1016/j.expneurol.2008.03.007. Epub 2008 Mar 21.
4
Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.蓝斑核消融加剧 P301S tau 转基因小鼠的认知缺陷、神经病理学和致死性。
J Neurosci. 2018 Jan 3;38(1):74-92. doi: 10.1523/JNEUROSCI.1483-17.2017. Epub 2017 Nov 13.
5
Onset of hippocampal network aberration and memory deficits in P301S tau mice are associated with an early gene signature.P301S tau 小鼠中海马网络异常和记忆缺陷的发生与早期基因特征相关。
Brain. 2020 Jun 1;143(6):1889-1904. doi: 10.1093/brain/awaa133.
6
Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.在一种新型突变tau转基因小鼠中,阿尔茨海默病样tau神经病理学导致记忆缺陷和功能性突触丧失,且无任何运动功能障碍。
Am J Pathol. 2006 Aug;169(2):599-616. doi: 10.2353/ajpath.2006.060002.
7
Early behavioural markers of disease in P301S tau transgenic mice.P301S tau 转基因小鼠疾病的早期行为标志物。
Behav Brain Res. 2010 Mar 17;208(1):250-7. doi: 10.1016/j.bbr.2009.12.002. Epub 2009 Dec 11.
8
Impaired plasticity of cortical dendritic spines in P301S tau transgenic mice.P301S tau 转基因小鼠大脑皮层树突棘可塑性受损。
Acta Neuropathol Commun. 2013 Dec 17;1:82. doi: 10.1186/2051-5960-1-82.
9
Hepatitis B core VLP-based mis-disordered tau vaccine elicits strong immune response and alleviates cognitive deficits and neuropathology progression in Tau.P301S mouse model of Alzheimer's disease and frontotemporal dementia.基于乙肝核心 VLP 的错误折叠 tau 疫苗可诱发强烈免疫应答,并改善 Tau.P301S 阿尔茨海默病和额颞叶痴呆小鼠模型的认知缺陷和神经病理学进展。
Alzheimers Res Ther. 2018 Jun 19;10(1):55. doi: 10.1186/s13195-018-0378-7.
10
TFEB Overexpression in the P301S Model of Tauopathy Mitigates Increased PHF1 Levels and Lipofuscin Puncta and Rescues Memory Deficits.tau 病 P301S 模型中 TFEB 的过表达可减轻 PHF1 水平升高和脂褐素斑点,并挽救记忆缺陷。
eNeuro. 2016 May 23;3(2). doi: 10.1523/ENEURO.0042-16.2016. eCollection 2016 Mar-Apr.

引用本文的文献

1
Detecting the Undetectable: Advances in Methods for Identifying Small Tau Aggregates in Neurodegenerative Diseases.检测难以检测到的物质:神经退行性疾病中小tau蛋白聚集体鉴定方法的进展
Chembiochem. 2025 Apr 1;26(7):e202400877. doi: 10.1002/cbic.202400877. Epub 2025 Jan 8.
2
USP9X-mediated deubiquitination of Raptor contributes to autophagy impairment and memory deficits in P301S mice.USP9X 介导的 Raptor 去泛素化导致 P301S 小鼠自噬损伤和记忆缺陷。
Cell Commun Signal. 2024 Oct 24;22(1):516. doi: 10.1186/s12964-024-01872-8.
3
Tau P301S Transgenic Mice Develop Gait and Eye Movement Impairments That Mimic Progressive Supranuclear Palsy.
Tau P301S转基因小鼠出现模仿进行性核上性麻痹的步态和眼球运动障碍。
bioRxiv. 2024 Oct 31:2024.09.20.614197. doi: 10.1101/2024.09.20.614197.
4
Identification of AS1842856 as a novel small-molecule GSK3α/β inhibitor against Tauopathy by accelerating GSK3α/β exocytosis.通过加速糖原合酶激酶3α/β(GSK3α/β)的胞吐作用,鉴定AS1842856为一种新型的针对 Tau 蛋白病的小分子 GSK3α/β 抑制剂。
Aging Cell. 2025 Jan;24(1):e14336. doi: 10.1111/acel.14336. Epub 2024 Sep 17.
5
Impairment of Nrf2 signaling in the hippocampus of P301S tauopathy mice model aligns with the cognitive impairment and the associated neuroinflammation.P301S 型 tau 蛋白病小鼠模型海马体中 Nrf2 信号通路的损伤与认知障碍及相关神经炎症一致。
J Inflamm (Lond). 2024 Aug 6;21(1):29. doi: 10.1186/s12950-024-00396-9.
6
Effect of the ROCK inhibitor fasudil on the brain proteomic profile in the tau transgenic mouse model of Alzheimer's disease.ROCK抑制剂法舒地尔对阿尔茨海默病tau转基因小鼠模型脑蛋白质组图谱的影响。
Front Aging Neurosci. 2024 Feb 19;16:1323563. doi: 10.3389/fnagi.2024.1323563. eCollection 2024.
7
DAP12 deficiency alters microglia-oligodendrocyte communication and enhances resilience against tau toxicity.DAP12缺陷改变了小胶质细胞与少突胶质细胞之间的通讯,并增强了对tau毒性的抵抗力。
bioRxiv. 2023 Oct 28:2023.10.26.563970. doi: 10.1101/2023.10.26.563970.
8
Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model.tau 病模型中行为、形态和转录组变化的纵向特征。
Aging (Albany NY). 2023 Nov 3;15(21):11697-11719. doi: 10.18632/aging.205057.
9
Frontotemporal Dementia P301L Mutation Potentiates but Is Not Sufficient to Cause the Formation of Cytotoxic Fibrils of Tau.额颞叶痴呆 P301L 突变增强但不足以导致 Tau 的细胞毒性纤维的形成。
Int J Mol Sci. 2023 Oct 8;24(19):14996. doi: 10.3390/ijms241914996.
10
Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.阿尔茨海默病转基因小鼠模型的批判性思考:当前研究与未来展望
Sci China Life Sci. 2023 Dec;66(12):2711-2754. doi: 10.1007/s11427-022-2357-x. Epub 2023 Jul 17.